Fig. 8From: Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysisBias assessment (funnel) plots of publication bias for the outcomes evaluated (a culture conversion; b treatment success; c myelosuppression; d neuropathy; e discontinuation due to linezolid adverse effects; f presence of any other adverse events)Back to article page